{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T23:41:12Z","timestamp":1789170072717,"version":"build-2803163510"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100004897","name":"Pennsylvania Department of Health","doi-asserted-by":"publisher","award":["4100072562"],"award-info":[{"award-number":["4100072562"]}],"id":[{"id":"10.13039\/100004897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["CA178177-05"],"award-info":[{"award-number":["CA178177-05"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R21CA170121"],"award-info":[{"award-number":["R21CA170121"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01CA167535"],"award-info":[{"award-number":["R01CA167535"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.nano.2021.102383","type":"journal-article","created":{"date-parts":[[2021,3,14]],"date-time":"2021-03-14T00:41:42Z","timestamp":1615682502000},"page":"102383","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Preferential uptake of antibody targeted calcium phosphosilicate nanoparticles by metastatic triple negative breast cancer cells in co-cultures of human metastatic breast cancer cells plus bone osteoblasts"],"prefix":"10.1016","volume":"34","author":[{"given":"Karen M.","family":"Bussard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher M.","family":"Gigliotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernadette M.","family":"Adair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenna M.","family":"Snyder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas T.","family":"Gigliotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Welley S.","family":"Loc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zachary R.","family":"Wilczynski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zi-Kui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kacey","family":"Meisel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia","family":"Zemanek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea M.","family":"Mastro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison B.","family":"Shupp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"McGovern","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gail L.","family":"Matters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James H.","family":"Adair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.nano.2021.102383_bb0005","first-page":"7","article-title":"Cancer statistics, 2020","volume":"70","author":"Siegel","year":"2020","journal-title":"CA:Cancer J Clin"},{"issue":"3","key":"10.1016\/j.nano.2021.102383_bb0010","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1007\/s10549-012-2315-y","article-title":"Clinical and biologic features of triple-negative breast cancers in a large cohort of patients with long-term follow-up","volume":"136","author":"Malorni","year":"2012","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"10.1016\/j.nano.2021.102383_bb0015","doi-asserted-by":"crossref","first-page":"290","DOI":"10.4149\/neo_2013_038","article-title":"Distant metastasis in triple-negative breast cancer","volume":"60","author":"Tseng","year":"2013","journal-title":"Neoplasma"},{"key":"10.1016\/j.nano.2021.102383_bb0020","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/nrc867","article-title":"Metastasis to bone: causes, consequences and therapeutic opportunities","volume":"2","author":"Mundy","year":"2002","journal-title":"Nat Rev Cancer"},{"issue":"5","key":"10.1016\/j.nano.2021.102383_bb0025","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1007\/s13346-018-0551-3","article-title":"Metastatic and triple-negative breast cancer: challenges and treatment options","volume":"8","author":"Al-Mahmood","year":"2018","journal-title":"Drug Deliv Transl Res"},{"key":"10.1016\/j.nano.2021.102383_bb0030","unstructured":"Abraham T, Clawson GA, Linton SS, McGovern CO, Tang X, Adair JH, et al., editors. Bio-distribution of near infrared imaging agent loaded targeted drug nanoparticle carriers in highly fibrotic pancreatic tumor determined using multiphoton and harmonic generation imaging. Imaging, Manipulation, and Analysis of Biomolecules, Cells, and Tissues XVI; 2018: International Society for Optics and Photonics, pp. 1049729-1-5."},{"issue":"10","key":"10.1016\/j.nano.2021.102383_bb0035","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1021\/nn800448r","article-title":"Near-infrared emitting fluorophore-doped calcium phosphate nanoparticles for in vivo imaging of human breast cancer","volume":"2","author":"Alt\u0131noglu","year":"2008","journal-title":"ACS Nano"},{"issue":"7","key":"10.1016\/j.nano.2021.102383_bb0040","doi-asserted-by":"crossref","first-page":"5325","DOI":"10.1021\/nn2005766","article-title":"Targeted indocyanine-green-loaded calcium phosphosilicate nanoparticles for in vivo photodynamic therapy of leukemia","volume":"5","author":"Barth","year":"2011","journal-title":"ACS Nano"},{"issue":"3","key":"10.1016\/j.nano.2021.102383_bb0045","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1021\/nn304862b","article-title":"PhotoImmunoNanoTherapy reveals an anticancer role for sphingosine kinase 2 and dihydrosphingosine-1-phosphate","volume":"7","author":"Barth","year":"2013","journal-title":"ACS Nano"},{"issue":"3","key":"10.1016\/j.nano.2021.102383_bb0050","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1021\/nn901297q","article-title":"Bioconjugation of calcium phosphosilicate composite nanoparticles for selective targeting of human breast and pancreatic cancers in vivo","volume":"4","author":"Barth","year":"2010","journal-title":"ACS Nano"},{"issue":"1","key":"10.1016\/j.nano.2021.102383_bb0055","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1089\/nat.2016.0621","article-title":"A cholecystokinin B receptor-specific DNA aptamer for targeting pancreatic ductal adenocarcinoma","volume":"27","author":"Clawson","year":"2017","journal-title":"Nucleic acid therapeutics"},{"issue":"9","key":"10.1016\/j.nano.2021.102383_bb0060","doi-asserted-by":"crossref","first-page":"4967","DOI":"10.1021\/nn102324e","article-title":"Nanoparticulate alternatives for drug delivery","volume":"4","author":"Adair","year":"2010","journal-title":"ACS Nano"},{"issue":"12","key":"10.1016\/j.nano.2021.102383_bb0065","doi-asserted-by":"crossref","first-page":"4108","DOI":"10.1021\/nl8019888","article-title":"Encapsulation of organic molecules in calcium phosphate nanocomposite particles for intracellular imaging and drug delivery","volume":"8","author":"Morgan","year":"2008","journal-title":"Nano Lett"},{"issue":"3","key":"10.1016\/j.nano.2021.102383_bb0070","doi-asserted-by":"crossref","first-page":"400a","DOI":"10.1016\/j.bpj.2008.12.2035","article-title":"Photophysical characterization of dye-encapsulated calcium phosphate nanoparticles","volume":"96","author":"Muddana","year":"2009","journal-title":"Biophysical Journal"},{"issue":"1","key":"10.1016\/j.nano.2021.102383_bb0075","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1309\/LMGLMZ8CIYMFNOGX","article-title":"Calcium, magnesium, and phosphate","volume":"45","author":"Bazydio","year":"2014","journal-title":"Lab Med"},{"issue":"3916","key":"10.1016\/j.nano.2021.102383_bb0080","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1126\/science.167.3916.279","article-title":"Silicon: a possible factor in bone calcification","volume":"167","author":"Carlisle","year":"1970","journal-title":"Science"},{"key":"10.1016\/j.nano.2021.102383_bb0085","first-page":"123","article-title":"Silicon as an essential trace element in animal nutrition","volume":"121","author":"Carlisle","year":"1986","journal-title":"Ciba Found Symp"},{"issue":"4","key":"10.1016\/j.nano.2021.102383_bb0090","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.jtemb.2014.06.024","article-title":"Update on the possible nutritional importance of silicon","volume":"28","author":"Nielsen","year":"2014","journal-title":"J Trace Elem Med Biol"},{"issue":"7","key":"10.1016\/j.nano.2021.102383_bb0095","doi-asserted-by":"crossref","first-page":"936","DOI":"10.3390\/nu10070936","article-title":"Calcium and phosphate metabolism, blood lipids and intestinal sterols in human intervention studies using different sources of phosphate as supplements-pooled results and literature search","volume":"10","author":"Trautvetter","year":"2018","journal-title":"Nutrients."},{"issue":"7","key":"10.1016\/j.nano.2021.102383_bb0100","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1016\/j.nano.2017.06.017","article-title":"Effective encapsulation and biological activity of phosphorylated chemotherapeutics in calcium phosphosilicate nanoparticles for the treatment of pancreatic cancer","volume":"13","author":"Loc","year":"2017","journal-title":"Nanomedicine: Nanotechnology, Biology and Medicine"},{"key":"10.1016\/j.nano.2021.102383_bb0105","doi-asserted-by":"crossref","unstructured":"Abraham T., McGovern C.O., Linton S.S., Wilczynski Z., Adair J.H., Matters G.L. Aptamer-targeted calcium phosphosilicate nanoparticles for effective imaging of pancreatic and prostate cancer, International Journal of Nanomedicine, 16, 2021, 2297\u20132309.","DOI":"10.2147\/IJN.S295740"},{"key":"10.1016\/j.nano.2021.102383_bb0110","doi-asserted-by":"crossref","unstructured":"Hecker SJ, and Erion, M. D. Prodrugs of phosphates and phosphonates. J Med Chem 51, 2328\u201345. 2008;51:2328\u201345.","DOI":"10.1021\/jm701260b"},{"key":"10.1016\/j.nano.2021.102383_bb0115","doi-asserted-by":"crossref","unstructured":"Matuo R, Sousa, F. G., Escargueil, A. E., Grivicich, I., Garcia-Santos, D., Chies, J. A., Saffi, J., Larsen, A. K., and Henriques, J. A. 5-Fluorouracil and its active metabolite FdUMP cause DNA damage in human SW620 colon adenocarcinoma cell line. Appl Toxcicol 2009;29:308\u201316.","DOI":"10.1002\/jat.1411"},{"key":"10.1016\/j.nano.2021.102383_bb0120","doi-asserted-by":"crossref","first-page":"9154","DOI":"10.1021\/cr5002035","article-title":"Synthesis of nucleoside phosphate and phosphonate prodrugs","volume":"114","author":"Pradere","year":"2014","journal-title":"Chem Rev"},{"issue":"2","key":"10.1016\/j.nano.2021.102383_bb0125","doi-asserted-by":"crossref","first-page":"e306","DOI":"10.1016\/j.clbc.2018.12.004","article-title":"Single-agent gemcitabine vs. carboplatin-gemcitabine in advanced breast cancer: a retrospective comparison of efficacy and safety profiles","volume":"19","author":"Vernieri","year":"2019","journal-title":"Clin Breast Cancer"},{"issue":"52","key":"10.1016\/j.nano.2021.102383_bb0130","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000018513","article-title":"Pilot study of docetaxel combined with lobaplatin or gemcitabine for recurrent and metastatic breast cancer","volume":"98","author":"Li","year":"2019","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.nano.2021.102383_bb0135","doi-asserted-by":"crossref","first-page":"3753","DOI":"10.2147\/DDDT.S219489","article-title":"Smart targeting to improve cancer therapeutics","volume":"13","author":"Morales-Cruz","year":"2019","journal-title":"Drug Des Devel Ther"},{"issue":"6","key":"10.1016\/j.nano.2021.102383_bb0140","first-page":"916","article-title":"Transferrin receptor 1 in cancer: a new sight for cancer therapy","volume":"8","author":"Shen","year":"2018","journal-title":"Am J Cancer Res"},{"issue":"1","key":"10.1016\/j.nano.2021.102383_bb0145","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/s42255-018-0005-8","article-title":"Transferrin receptor 2 controls bone mass and pathological bone formation via BMP and Wnt signaling","volume":"1","author":"Rauner","year":"2019","journal-title":"Nat Metab"},{"issue":"3","key":"10.1016\/j.nano.2021.102383_bb0150","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1210\/endo-126-3-1742","article-title":"Characterization of the transferrin receptor in UMR-106-01 osteoblast-like cells","volume":"126","author":"Kasai","year":"1990","journal-title":"Endocrinology"},{"key":"10.1016\/j.nano.2021.102383_bb0155","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/51.5.1409","article-title":"A human cell line from a pleural effusion derived from a breast carcinoma","volume":"51","author":"Soule","year":"1973","journal-title":"J Natl Cancer Inst"},{"issue":"21","key":"10.1016\/j.nano.2021.102383_bb0160","doi-asserted-by":"crossref","first-page":"6728","DOI":"10.1158\/0008-5472.CAN-11-1870","article-title":"An iron regulatory gene signature predicts outcome in breast cancer","volume":"71","author":"Miller","year":"2011","journal-title":"Cancer Res"},{"issue":"2","key":"10.1016\/j.nano.2021.102383_bb0165","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.cmet.2013.01.007","article-title":"The IRP1-HIF-2alpha axis coordinates iron and oxygen sensing with erythropoiesis and iron absorption","volume":"17","author":"Anderson","year":"2013","journal-title":"Cell Metab"},{"issue":"6","key":"10.1016\/j.nano.2021.102383_bb0170","doi-asserted-by":"crossref","DOI":"10.3390\/cancers10060182","article-title":"Cancer metastases to bone: concepts, mechanisms, and interactions with bone osteoblasts","volume":"10","author":"Shupp","year":"2018","journal-title":"Cancers."},{"issue":"13","key":"10.1016\/j.nano.2021.102383_bb0175","doi-asserted-by":"crossref","first-page":"3111","DOI":"10.1096\/fasebj.4.13.2210157","article-title":"Relationship of cell growth to the regulation of tissue-specific gene expression during osteoblast differentiation","volume":"4","author":"Stein","year":"1990","journal-title":"FASEB J"},{"issue":"687","key":"10.1016\/j.nano.2021.102383_bb0180","article-title":"Nanoparticle-mediated drug delivery for treatment of ischemic heart disease","volume":"8","author":"Fan","year":"2020","journal-title":"Frontiers in Bioengineering and Biotechnology"},{"issue":"1","key":"10.1016\/j.nano.2021.102383_bb0185","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s12951-018-0392-8","article-title":"Rodriguez-Torres MdP, Acosta-Torres LS, et al. Nano based drug delivery systems: recent developments and future prospects","volume":"16","author":"Patra","year":"2018","journal-title":"Journal of Nanobiotechnology"},{"issue":"1","key":"10.1016\/j.nano.2021.102383_bb0190","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jsps.2017.10.012","article-title":"Applications of nanoparticle systems in drug delivery technology","volume":"26","author":"Rizvi","year":"2018","journal-title":"Saudi Pharm J"},{"issue":"11","key":"10.1016\/j.nano.2021.102383_bb0195","doi-asserted-by":"crossref","first-page":"6221","DOI":"10.7314\/APJCP.2013.14.11.6221","article-title":"Current progress in the treatment of metaplastic breast carcinoma","volume":"14","author":"Hu","year":"2013","journal-title":"Asian Pac J Cancer Prev"},{"issue":"1","key":"10.1016\/j.nano.2021.102383_bb0200","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3109\/09540261.2013.852971","article-title":"A review of clinical aspects of breast cancer","volume":"26","author":"Libson","year":"2014","journal-title":"Int Rev Psychiatry"},{"issue":"4","key":"10.1016\/j.nano.2021.102383_bb0205","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1007\/s00280-014-2551-4","article-title":"Phase II gemcitabine and capecitabine combination therapy in recurrent or metastatic breast cancer patients pretreated with anthracycline and taxane","volume":"74","author":"Park","year":"2014","journal-title":"Cancer Chemother Pharmacol"},{"issue":"3","key":"10.1016\/j.nano.2021.102383_bb0210","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1093\/annonc\/mdn661","article-title":"Phase II trial of weekly nab (nanoparticle albumin-bound)-paclitaxel (nab-paclitaxel) (Abraxane) in combination with gemcitabine in patients with metastatic breast cancer (N0531)","volume":"20","author":"Roy","year":"2009","journal-title":"Ann Oncol"},{"issue":"1","key":"10.1016\/j.nano.2021.102383_bb0215","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s13058-020-01296-5","article-title":"Triple-negative breast cancer molecular subtyping and treatment progress","volume":"22","author":"Yin","year":"2020","journal-title":"Breast Cancer Research"},{"issue":"7","key":"10.1016\/j.nano.2021.102383_bb0220","doi-asserted-by":"crossref","first-page":"499","DOI":"10.21037\/atm.2020.03.194","article-title":"Molecular subtypes and precision treatment of triple-negative breast cancer","volume":"8","author":"Zhao","year":"2020","journal-title":"Ann Transl Med"},{"issue":"12","key":"10.1016\/j.nano.2021.102383_bb0225","first-page":"2821","article-title":"ER+ metastatic breast cancer: past, present, and a prescription for an apoptosis-targeted future","volume":"9","author":"Rozeboom","year":"2019","journal-title":"Am J Cancer Res"},{"key":"10.1016\/j.nano.2021.102383_bb0230","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.2147\/CMAR.S245949","article-title":"Intercalary reconstruction of the \"ultra-critical sized bone defect\" by 3D-printed porous prosthesis after resection of tibial malignant tumor","volume":"12","author":"Zhao","year":"2020","journal-title":"Cancer management and research"},{"issue":"2","key":"10.1016\/j.nano.2021.102383_bb0235","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1385\/MO:23:2:147","article-title":"Paclitaxel-carboplatin combination chemotherapy in advanced breast cancer: accumulating evidence for synergy, efficacy, and safety","volume":"23","author":"Pentheroudakis","year":"2006","journal-title":"Med Oncol"},{"issue":"5","key":"10.1016\/j.nano.2021.102383_bb0240","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1093\/annonc\/mdq041","article-title":"Weekly paclitaxel plus carboplatin is an effective nonanthracycline-containing regimen as neoadjuvant chemotherapy for breast cancer","volume":"21","author":"Chen","year":"2010","journal-title":"Ann Oncol"},{"issue":"2","key":"10.1016\/j.nano.2021.102383_bb0245","doi-asserted-by":"crossref","first-page":"938","DOI":"10.7150\/thno.37443","article-title":"Monoclonal antibody-based molecular imaging strategies and theranostic opportunities","volume":"10","author":"Dammes","year":"2020","journal-title":"Theranostics"},{"issue":"1","key":"10.1016\/j.nano.2021.102383_bb0250","doi-asserted-by":"crossref","first-page":"51","DOI":"10.2967\/jnumed.117.192286","article-title":"Noninvasive (89)Zr-transferrin PET shows improved tumor targeting compared with (18)F-FDG PET in MYC-overexpressing human triple-negative breast cancer","volume":"59","author":"Henry","year":"2018","journal-title":"J Nucl Med"}],"container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963421000265?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963421000265?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T04:19:50Z","timestamp":1778818790000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1549963421000265"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":50,"alternative-id":["S1549963421000265"],"URL":"https:\/\/doi.org\/10.1016\/j.nano.2021.102383","relation":{},"ISSN":["1549-9634"],"issn-type":[{"value":"1549-9634","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preferential uptake of antibody targeted calcium phosphosilicate nanoparticles by metastatic triple negative breast cancer cells in co-cultures of human metastatic breast cancer cells plus bone osteoblasts","name":"articletitle","label":"Article Title"},{"value":"Nanomedicine: Nanotechnology, Biology and Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nano.2021.102383","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102383"}}